This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
BC200-Driven Translational Regulation as a Therapeutic Target and Biomarker in Tubo-Ovarian High-Grade Serous Carcinoma
In vivo modelling of chromosome instability in tubo-ovarian high grade serous carcinoma
Electrochemical Quantification of Chemotherapy Resistance
Delving deeper into chaos of ovarian cancer genomes—from telomere-to-telomere
The Manitoba Ovarian Cancer Biobank Program (MOBP)
Testing the in vitro mechanism and in vivo efficacy of an experimental drug to kill epithelial ovarian cancer
Engaging Indigenous Communities to Understand Perspectives on Genetic Testing and Risk-Reducing Surgery for Ovarian Cancer in Alberta, Canada
Deciphering phosphorylation-dependent signal rewiring in ovarian and endometrial cancer
Evaluating the Performance of a Blood Test for Early Cancer Detection in individuals at high risk
Patient-centred Hereditary Ovarian Cancer Prevention and Survivorship Care in Canada
